
    
      (i) To assess the effect of adjunctive topical steroids in the combined treatment with UVBnb
      and dithranol on the remission time after therapy till a relapse of psoriasis defined as 50%
      loss of PASI (Psoriasis Area and Severity Index) improvement obtained through the antecedent
      treatment.

      (ii) To assess the impact of adjuvant topical steroids in the combined treatment with UVBnb
      and dithranol on the clearing time of psoriasis lesions under therapy (PASI 75).

        -  Trial with medicinal product
    
  